M. Paye

发表

Prognostic significance of urokinase Plasminogen Activator and Plasminogen Activator Inhibitor-1 mRNA expression in advanced breast cancer

A. Puisieux, P. Leissner, T. Verjat, 2006 .

Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis

C. Auffray, M. Paye, B. Mougin, 2010, Genes and Immunity.

NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer

P. Lamy, P. Leissner, T. Verjat, 2006, Clinical chemistry and laboratory medicine.

Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis

M. Paye, B. Mougin, P. Miossec, 2011, PloS one.

Early kinetics of the transcriptional response of human leukocytes to staphylococcal superantigenic enterotoxins A and G.

F. Vandenesch, G. Lina, M. Paye, 2009, Microbial pathogenesis.

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer

A. Puisieux, P. Leissner, T. Verjat, 2006, BMC Cancer.

activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.

A. Puisieux, P. Leissner, T. Verjat, 2006 .

Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach

M. Paye, B. Mougin, F. Venet, 2014, Intensive Care Medicine Experimental.

Gene Expression Profiles in Alveolar Macrophages Induced by Lipopolysaccharide in Humans

T. van der Poll, P. Bresser, M. Paye, 2012, Molecular medicine.